# The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

> **NCT00275535** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 165 (actual)

## Conditions studied

- Kidney Diseases

## Interventions

- **DRUG:** Anti-thymocyte globulin
- **DRUG:** Mycophenolate mofetil
- **DRUG:** Prednisone
- **DRUG:** Tacrolimus
- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT00275535
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** 2007-11
- **Final completion:** 2008-12
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2011-12-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00275535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00275535, "The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00275535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*